TNF-mediated cytotoxicity of L929 cells: Role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes

Cytokine

Volumn 9, Issue 2, 1997, Pages 83-92

  O'Connell, M A ^a   Kelleher, D ^a   Liskamp, R M J ^b   Hall, N ^a   O'Neill, L A J ^a   Long, A ^a,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cytotoxicity; L929 fibrosarcoma; Phorbol 12 myristate 13 acetate; Protein kinase C; Staurosporine; Tumour necrosis factor

Indexed keywords

DACTINOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; STAUROSPORINE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN L 929; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0031081557     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0140     Document Type: Article

References (62)

1. 1. Tracey KJ, Vlassara H, Cerami A (1989) Cachectin/tumour necrosis factor. Lancet 20:1122-1126.
2. 2. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670.
3. 3. Helson L, Green S, Carswell EA, Old LJ (1975) Effect of tumour necrosis factor on cultured human melanoma cells. Nature 258:731-732.
4. 4. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumour necrosis factor from human monocytes. J Immunol Methods 95:99-105.
5. 5. Camussi G, Albano E, Tetla C, Bussolino F (1991) The molecular action of tumor necrosis factor-α. Eur J Biochem 202:3-14.
6. 6. Brockhaus M, Schoenfeld HJ, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
7. 7. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W (1993) Human TNF mutants with selective activity on the p55 receptor. Nature 361:266-269.
8. 8. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV (1991) The two receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296.
9. 9. Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, Stephens S, Kaslaris E, Kiossis D, Kollias G (1993) Wasting, ischemia and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol 151:1894-1906.
10. 10. Higuchi M, Aggarwal BB (1994) TNF induces internalisation of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550-3558.
11. 11. Heller RA, Song K, Fan N, Chang DJ (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56.
12. 12. Nophar Y, Kemper O, Brakebusch C, Engelmann H, Zwang R, Aderka D, Holtmann H, Wallach D (1990) Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278.
13. 13. Beyaert R, Vanhaesebroeck B, Heyninck K, Boone E, De Valck D, Schulze-Osthoff K, Haegeman G, Van Roy F, Fiers W (1993) Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine. Cancer Res 53:2623-2630.
14. 14. Guy GR, Cao X, Chua SP, Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267:1846-1852.
15. 15. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M (1989) Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 337:661-663.
16. 16. Van Lint J, Agostinis P, Vandevoorde V, Haegeman G, Fiers W, Merlevede W, Vandenabeele JR (1992) Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-related kinases in the tumor necrosis factor signal transduction pathway. J Biol Chem 267:25916-25921.
17. 17. Imamura K, Sherman ML, Spriggs D, Kufe D (1988) Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. J Biol Chem 263:10247-10253.
18. 18. Branellec D, Di Cremoux P, Barreau P, Calvo F, Chouib S (1992) Tumor necrosis factor cell lysis in vitro: relationship to cAMP accumulation and guanine nucleotide-binding proteins. Eur J Immunol 22:963-967.
19. 19. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
20. 20. Dekker LV, Parker PJ (1994) Protein kinase C - a question of specificity. Trends Biochem Sci 19:73-77.
21. 21. Matsubara N, Fuchimoto S, Orita K (1991) Tumour necrosis factor-α induces translocation of protein kinase C in tumour necrosis factor-sensitive cell lines. Immunol 73:457-459.
22. 22. Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J Immunol Methods 68:167-175.
23. 23. Green LM, Reade JL, Ware CF (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytokine and growth inhibitory lymphokines. J Immunol Methods 70: 257-268.
24. 24. Hay H, Cohen J (1989) Studies on the specificity of the L929 bioassay for the measurement of tumour necrosis factor. J Clin Lab Immunol 29:151-155.
25. 25. Meager A, Leung H, Woolley J (1989) Assays for tumour necrosis factor and related cytokines. J Immunol Methods 116:1-17.
26. 26. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77.
27. 27. Rothe M, Sarma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-κB by TNF Receptor 2 and CD40. Science 269:1424-1427.
28. 28. Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NFκB activation. Cell 81:495-504.
29. 29. Prezioso JA, Wang J, Kim M, Tweardy DJ, Gorelik E (1995) Augmentation of TNF cytotoxicity by protein kinase C inhibitors: role of arachidonic acid and manganese superoxide dismutase. Cytokine 7:517-525.
30. 30. Hamamoto Y, Matsuyama T, Yamamoto N, Kobayashi N (1990) Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor. Cancer Res 50:5287-5290.
31. 31. Ways DK, Cook PP, Webster C, Parker PJ (1992) Effect of phorbol esters on protein kinase C-ζ. J Biol Chem 267:4799-7805.
32. 32. Kazanietz MG, Bustelo XR, Barbacid M, Kolch W, Mischak H, Wong G, Pettit GR, Bruns JD, Blumberg PM (1994) Zinc finger domains and phorbol ester pharmacore. Analysis of binding to mutated form of protein kinase C ζ and the vav and c-raf proto-oncogene products. J Biol Chem 269:11590-11594.
33. 33. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF (1993) Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-βII, -∈, -ζ and -η. J Biol Chem 268:20110-20115.
34. 34. Devalia V, Thomas NSB, Roberts PJ, Jones HM, Linch DC (1992) Down-regulation of human protein kinase C α is associated with terminal neutrophil differentiation. Blood 80:68-76.
35. 35. Finkenzeller G, Marme D, Hug H (1992) Inducible overexpression of human protein kinase C α in NIH3T3 fibroblasts results in growth abnormalities. Cell Signal 4:163-177.
36. 36. Jaattela M, Wissing D (1993) Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med 177:231-236.
37. 37. Eichholtz T, De Bont DBA, De Widt J, Liskamp RMJ, Ploegh HL (1993) A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 268:1982-1986.
38. 38. Courage C, Budworth J, Gescher A (1995) Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br J Cancer 71:697-704.
39. 39. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto N, Tornita F (1986) Staurosporine, a potent inhibitor of phospholipid/calcium-dependent protein kinase. Biochem Biophys Res Commun 135:397-402.
40. 40. Bradshaw D, Hill CH, Nixon JS, Wilkinson SE (1993) Therapeutic potential of protein kinase C inhibitors. Agents Actions 38:135-147.
41. 41. Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, Elliott LH, Gibson VM, Greenham A, Hallam TJ, Harris W, Hill CH, Hutchings A, Lamont AG, Lawton G, Lewis EJ, Maw A, Nixon JS, Pole D, Wadsworth J, Wilkinson SE (1994) Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J Pharm Exp Ther 268:922-929.
42. 42. Ruegg UT, Burgess GM (1989) Staurosporine, K-252 and UCN-01: potent but non-speccific inhibitors of protein kinases. Trends Biochem Sci 10:218-220.
43. 43. Dlugosz AA, Yuspa SH (1991) Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Cancer Res 51:4677-4684.
44. 44. Pavlovic-Surjancev B, Cahill AL, Perlman RL (1993) Staurosporine activates a 60,000Mr protein kinase in bovine chromaffin cells that phosphorylates myelin basic protein in vitro. J Neurochem 61:697-703.
45. 45. Yoshimura M, Nishikawa A, Nishiura T, Ihara Y, Kanayama Y, Matsuzawa Y, Taniguchi N (1995) Cell spreading in Colo 201 by staurosporine is α3 β1 integrin-mediated with tyrosine phosphorylation of src and tensin. J Biol Chem 270: 2298-2304.
46. 46. Kelleher D, Long A (1992) Development and characterisation of a protein kinase C β-isozyme-deficient T-cell line. FEBS Lett 301:310-314.
47. 47. Mahon TM, Brennan P, O'Neill LAJ (1993) Evidence for a redox-sensitive protein tyrosine kinase in nuclear factor κB activation and interleukin 2 production in EL4.NOB1 cells. Biochem Soc Trans 21:389S.
48. 48. Thorp KM, Southern C, Matthews N (1994) Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells. Immunol 81:546-550.
49. 49. Zhang L, Higuchi M, Totpal K, Chaturvedi MM, Aggarwal BB (1994) Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response. J Biol Chem 269:10270-10279.
50. 50. Kiley SC, Parker PJ, Fabbro D, Jaken S (1992) Differential regulation of protein kinase C isozymes by thyrotrophin-releasing hormone in GH4C1 cells. J Biol Chem 266:23761-23768.
51. 51. Kiley SC, Parker PJ, Fabbro D, Jaken S (1992) Selective redistribution of protein kinase C isozymes by thapsigargin and staurosporine. Carcinogenesis 13:1997-2001.
52. 52. Borner C, Guadagno SN, Fabbro D, Weinstein IB (1992) Expression of four protein kinase C isoforms in rat fibroblasts. J Biol Chem 267:12892-12899.
53. 53. Zhou G, Wooten MW, Coleman ES (1994) Regulation of atypical ζ-protein kinase C in cellular signaling. Exp Cell Res 214:1-11.
54. 54. Nishikawa K, Yamamoto S, Nagumo H, Maruyama K, Kato R (1995) The presence of phorbol ester responsive and non-responsive forms of the ζ isozyme of protein kinase C in mouse epidermal cells. Cell Signal 7:491-504.
55. 55. McGlynn E, Liebetanz J, Reutener S, Wood J, Lydon NB, Hofstetter H, Vanek M, Meyer T, Fabbro D (1992) Expression and partial characterisation of rat protein kinase C δ and protein kinase C ζ in insect cells using recombinant baculovirus. J Cell Biochem 49:239-250.
56. 56. Liyanage M, Frith D, Livneh E, Stabel S (1992) Protein kinase C group B members PKC-δ, -∈, -ζ, and PKC-L (η). Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J 283:781-787.
57. 57. Schutze S, Nottrott S, Pfizenmaier K, Kronke M (1990) Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C. J Immunol 144: 2604-2608.
58. 58. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K (1995) PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961-1969.
59. 59. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE (1989) Potent selective inhibitors of protein kinase C. FEBS Lett 259:61-63.
60. 60. Chakravarthy BR, Bussey A, Whitfield JF, Sikorska M, Williams RE, Durkin JP (1991) The direct measurement of protein kinase C (PKC) activity in isolated membranes using a selective peptide substrate. Anal Biochem 196:144-150.
61. 61. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram levels of protein utilising the principle of protein-dye binding, Anal Biochem 72:248-254.
62. 62. Ohno S, Akita Y, Konno Y, Imajoh S, Suzuki K (1988) A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell 53:731-741.